Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chung M. Wong, Douglas L. Anderton, Sallie Smith-Schneider, Megan A. Wing, Melissa C. Greven & Kathleen F. Arcaro. (2010) Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics 5:7, pages 645-655.
Read now
Read now
Nur Buyru, Julide Altinisik, Filiz Ozdemir, Semra Demokan & Nejat Dalay. (2009) Methylation Profiles in Breast Cancer. Cancer Investigation 27:3, pages 307-312.
Read now
Read now
Articles from other publishers (53)
Pierina Danos, Stefano Giannoni‐Luza, Alexis Germán Murillo Carrasco, Oscar Acosta, Maria Luisa Guevara‐Fujita, José Manuel Cotrina Concha, Henry Guerra Miller, Joseph Pinto Oblitas, Alfredo Aguilar Cartagena, Jhajaira M. Araujo, Ricardo Fujita & José Luis Buleje Sono. (2023)
Promoter hypermethylation of
RARB
and
GSTP1
genes in plasma cell‐free
DNA
as breast cancer biomarkers in Peruvian women
. Molecular Genetics & Genomic Medicine.
Crossref
Crossref
Qingfeng Guo & Yuming Hua. (2021) The assessment of circulating cell-free DNA as a diagnostic tool for breast cancer: an updated systematic review and meta-analysis of quantitative and qualitative ssays. Clinical Chemistry and Laboratory Medicine (CCLM) 59:9, pages 1479-1500.
Crossref
Crossref
Xin Chen, Xiaotang Wu & Wen Lei. (2021)
USP44
hypermethylation promotes cell proliferation and metastasis in breast cancer
. Future Oncology 17:3, pages 279-289.
Crossref
Crossref
Thejaswini Venkatesh, Sanu Thankachan, Shama Prasada Kabekkodu, Shrijeet Chakraborti & Padmanaban S. Suresh. 2021. Epigenetics and Reproductive Health. Epigenetics and Reproductive Health
295
324
.
Shiyang Pan & Jiexin Zhang. 2021. Clinical Molecular Diagnostics. Clinical Molecular Diagnostics
427
435
.
Niki Kougioumtsidou, Eleftherios Vavoulidis, Maria Nasioutziki, Marianthi Symeonidou, Georgios Chrysostomos Pratilas, Evangelia Mareti, Stamatios Petousis, Anthoula Chatzikyriakidou, Gregorios Grimbizis, Theodoros Theodoridis, Dimosthenis Miliaras, Konstantinos Dinas & Leonidas Zepiridis. (2020)
DNA
methylation patterns of
RAR
‐β2 and
RASSF1A
gene promoters in
FNAB
samples from Greek population with benign or malignant breast lesions
. Diagnostic Cytopathology 49:1, pages 153-164.
Crossref
Crossref
Manny D. Bacolod, Jianmin Huang, Sarah F. Giardina, Philip B. Feinberg, Aashiq H. Mirza, Alexander Swistel, Steven A. Soper & Francis Barany. (2020) Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection. BMC Cancer 20:1.
Crossref
Crossref
Ming Qi & Xiang Xiong. (2018) Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer. Medicine 97:51, pages e13666.
Crossref
Crossref
Marwa H. Saied, Aya Samy Rady, Galal Mustafa Abo El Naga & Ola A. Sharaki. (2018) Clinical Utility of promoter methylation of the tumor suppressor genes DKK3, and RASSF1A in breast cancer patients. Egyptian Journal of Medical Human Genetics 19:2, pages 87-90.
Crossref
Crossref
Yan Li, De-guo Lu, Ying-mei Ma & Hongxiang Liu. (2016)
Association between Retinoic
acid receptor-β
hypermethylation and NSCLC risk: a meta-analysis and literature review
. Oncotarget 8:4, pages 5814-5822.
Crossref
Crossref
Gabriel D. DakuboGabriel D. Dakubo. 2017. Cancer Biomarkers in Body Fluids. Cancer Biomarkers in Body Fluids
109
145
.
Qiuqiong Tang, Jie Cheng, Xue Cao, Harald Surowy & Barbara Burwinkel. (2016) Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clinical Epigenetics 8:1.
Crossref
Crossref
X Mao, C Gauche, M W H Coughtrie, C Bui, S Gulberti, F Merhi-Soussi, N Ramalanjaona, I Bertin-Jung, A Diot, D Dumas, N De Freitas Caires, A M Thompson, J-C Bourdon, M Ouzzine & S Fournel-Gigleux. (2016) The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer. Oncogene 35:38, pages 5043-5055.
Crossref
Crossref
A. K. Jha, V. Sharma, M. Nikbakht, V. Jain, A. Sehgal, N. Capalash & J. Kaur. (2016) A comparative analysis of methylation status of tumor suppressor genes in paired biopsy and serum samples from cervical cancer patients among north indian population. Russian Journal of Genetics 52:2, pages 226-230.
Crossref
Crossref
S. Kristiansen & G. Sölétormos. 2016. Medical Epigenetics. Medical Epigenetics
459
471
.
Isabelle Gingras, Libero Santarpia & Michail Ignatiadis. 2016. Molecular Pathology of Breast Cancer. Molecular Pathology of Breast Cancer
235
256
.
Nilufer Sayar, Gurbet Karahan, Ozlen Konu, Betul Bozkurt, Onder Bozdogan & Isik G. Yulug. (2015) Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer. Clinical Epigenetics 7:1.
Crossref
Crossref
Melanie Spitzwieser, Elisabeth Holzweber, Georg Pfeiler, Stefan Hacker & Margit Cichna-Markl. (2015) Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer. Breast Cancer Research 17:1.
Crossref
Crossref
Said S Moselhy, Taha A Kumosani, IH Kamal, JA Jalal, Hassan S Abdul Jabaar & Ashraf Dalol. (2013)
Hypermethylation of P
15
, P
16
, and E-cadherin genes in ovarian cancer
. Toxicology and Industrial Health 31:10, pages 924-930.
Crossref
Crossref
Saeed Pirouzpanah, Forough-Azam Taleban, Parvin Mehdipour & Morteza Atri. (2015) Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients. Journal of Molecular Medicine 93:8, pages 917-934.
Crossref
Crossref
Pantea Izadi & Mehrdad Noruzinia. 2015. Epigenetics Territory and Cancer. Epigenetics Territory and Cancer
281
309
.
S. N. Tamkovich, V. E. Voytsitskiy & P. P. Laktionov. (2014) Modern methods in breast cancer diagnostics. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 8:4, pages 302-313.
Crossref
Crossref
S.N. Tamkovich, V.E. Voytsitskiy & P.P. Laktionov. (2014) Modern approach of breast cancer diagnostics. Biomeditsinskaya Khimiya 60:2, pages 141-160.
Crossref
Crossref
Zainab Jafaar, Lacey Litchfield, Margarita Ivanova, Brandie Radde, Numan Al-Rayyan & Carolyn Klinge. (2014) β-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expression. International Journal of Oncology.
Crossref
Crossref
Kursat Oguz Yaykasli, Ertugrul Kaya & Emine Yaykasli. 2014. Omics Approaches in Breast Cancer. Omics Approaches in Breast Cancer
105
126
.
Feng Li, Yu-Chen Fan, Shuai Gao, Feng-Kai Sun, Yang Yang & Kai Wang. (2014) Methylation of serum insulin-like growth factor-binding protein 7 promoter in hepatitis B virus-associated hepatocellular carcinoma. Genes, Chromosomes and Cancer 53:1, pages 90-97.
Crossref
Crossref
Hiroaki Kawasaki, Emi Igawa, Rie Kohosozawa, Maho Kobayashi, Rika Nishiko & Hiroyuki Abe. (2013) Detection of aberrant methylation of tumor suppressor genes in plasma from cancer patients. Personalized Medicine Universe 2, pages 20-24.
Crossref
Crossref
Rosamaria Pinto, Brunella Pilato, Laura Ottini, Rossana Lambo, Giovanni Simone, Angelo Paradiso & Stefania Tommasi. (2013) Different methylation and MicroRNA expression pattern in male and female familial breast cancer. Journal of Cellular Physiology 228:6, pages 1264-1269.
Crossref
Crossref
Søren Kristiansen, Lars M. Jørgensen, Per Guldberg & György Sölétormos. (2018) Aberrantly Methylated DNA as a Biomarker in Breast Cancer. The International Journal of Biological Markers 28:2, pages 141-150.
Crossref
Crossref
Sameer MirzaGayatri SharmaRajinder ParshadSidhartha Datta GuptaPranav PandyaRanju Ralhan. (2013) Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated Proteins. Journal of Breast Cancer 16:1, pages 23.
Crossref
Crossref
Gayatri Sharma, Sameer Mirza, Rajinder Parshad, Siddartha Datta Gupta & Ranju Ralhan. (2012) DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients. Tumor Biology 33:6, pages 1837-1843.
Crossref
Crossref
Lien Van De Voorde, Reinhart Speeckaert, Dirk Van Gestel, Marc Bracke, Wilfried De Neve, Joris Delanghe & Marijn Speeckaert. (2012) DNA methylation-based biomarkers in serum of patients with breast cancer. Mutation Research/Reviews in Mutation Research 751:2, pages 304-325.
Crossref
Crossref
Kyong Park. (2012) Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer. International Journal of Oncology.
Crossref
Crossref
Melpomeni Kalofonou, Pantelis Georgiou, Chung-Pei Ou & Christofer Toumazou. (2012) An ISFET based translinear sensor for DNA methylation detection. Sensors and Actuators B: Chemical 161:1, pages 156-162.
Crossref
Crossref
Amy E. BonDurant, Zhiqing Huang, Regina S. Whitaker, Lauren R. Simel, Andrew Berchuck & Susan K. Murphy. (2011) Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer. Gynecologic Oncology 123:3, pages 581-587.
Crossref
Crossref
Georg Göbel, Doris Auer, Inge Gaugg, Alois Schneitter, Ralf Lesche, Elisabeth Müller-Holzner, Christian Marth & Günter Daxenbichler. (2011) Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients. Breast Cancer Research and Treatment 130:1, pages 109-117.
Crossref
Crossref
Ramin Radpour, Zeinab Barekati, Corina Kohler, Qing Lv, Nicole Bürki, Claude Diesch, Johannes Bitzer, Hong Zheng, Seraina Schmid & Xiao Yan Zhong. (2011) Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing a Blood-Based Test in Breast Cancer. PLoS ONE 6:1, pages e16080.
Crossref
Crossref
K.P.M. Suijkerbuijk, P.J. van Diest & E. van der Wall. (2011) Improving early breast cancer detection: focus on methylation. Annals of Oncology 22:1, pages 24-29.
Crossref
Crossref
Jennifer D. Brooks, Paul Cairns, Roy E. Shore, Catherine B. Klein, Isaac Wirgin, Yelena Afanasyeva & Anne Zeleniuch-Jacquotte. (2010) DNA methylation in pre-diagnostic serum samples of breast cancer cases: Results of a nested case–control study. Cancer Epidemiology 34:6, pages 717-723.
Crossref
Crossref
Saeed Pirouzpanah, Forough A. Taleban, Morteza Atri, Ali-Reza Abadi & Parvin Mehdipour. (2010) The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer. Cancer Causes & Control 21:12, pages 2101-2111.
Crossref
Crossref
Jo-Heon Kim, Min-Ho Shin, Sun-Seog Kweon, Min Ho Park, Jung Han Yoon, Ji Shin Lee, Chan Choi, Mary Jo Fackler & Saraswati Sukumar. (2010) Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women. Gynecologic Oncology 118:2, pages 176-181.
Crossref
Crossref
Gayatri Sharma, Sameer Mirza, Rajinder Parshad, Anurag Srivastava, Siddartha Datta Gupta, Pranav Pandya & Ranju Ralhan. (2010) Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Life Sciences 87:3-4, pages 83-91.
Crossref
Crossref
Lang Hu, Gang Chen, Hongping Yu & Xiaoqiang Qiu. (2010) Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma. Hepatology International 4:1, pages 423-432.
Crossref
Crossref
Allison JonesMatthias LechnerEvangelia-Ourania FourkalaRebecca Kristeleit & Martin Widschwendter. (2010) Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women’s cancers. Epigenomics 2:1, pages 9-38.
Crossref
Crossref
Sondes Karray-Chouayekh, Fatma Trifa, Abdelmajid Khabir, Nouredine Boujelbane, Tahia Sellami-Boudawara, Jamel Daoud, Mounir Frikha, Rachid Jlidi, Ali Gargouri & Raja Mokdad-Gargouri. (2009) Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients. Journal of Cancer Research and Clinical Oncology 136:2, pages 203-210.
Crossref
Crossref
Triantafillos Liloglou & John K. Field. 2010. Epigenetics and Cancer, Part B. Epigenetics and Cancer, Part B
177
207
.
E. Y. Rykova, P. P. Laktionov & V. V. Vlassov. 2010. Extracellular Nucleic Acids. Extracellular Nucleic Acids
93
128
.
Jennifer Brooks, Paul Cairns & Anne Zeleniuch-Jacquotte. (2009) Promoter methylation and the detection of breast cancer. Cancer Causes & Control 20:9, pages 1539-1550.
Crossref
Crossref
Chandra P. Prasad, Sameer Mirza, Gayatri Sharma, Rajinder Prashad, Siddhartha DattaGupta, Gayatri Rath & Ranju Ralhan. (2008) Epigenetic alterations of CDH1 and APC genes: Relationship with activation of Wnt/β-catenin Pathway in invasive ductal carcinoma of breast. Life Sciences 83:9-10, pages 318-325.
Crossref
Crossref
Sarangadhara Appala Raju Bagadi, Chandra Prakash Prasad, Jatinder Kaur, Anurag Srivastava, Rajinder Prashad, Siddartha Datta Gupta & Ranju Ralhan. (2008) Clinical significance of promoter hypermethylation of RASSF1A, RARβ2, BRCA1 and HOXA5 in breast cancers of Indian patients. Life Sciences 82:25-26, pages 1288-1292.
Crossref
Crossref
Sameer Mirza, Gayatri Sharma, Chandra P. Prasad, Rajinder Parshad, Anurag Srivastava, Siddartha Dutta Gupta & Ranju Ralhan. (2007) Promoter hypermethylation of TMS1, BRCA1, ERα and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sciences 81:4, pages 280-287.
Crossref
Crossref
Gayatri Sharma, Sameer Mirza, Chandra P. Prasad, Anurag Srivastava, Siddhartha Dutta Gupta & Ranju Ralhan. (2007) Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sciences 80:20, pages 1873-1881.
Crossref
Crossref
Chandra P. Prasad, Siddhartha D. Gupta, Gayatri Rath & Ranju Ralhan. (2007) Wnt Signaling Pathway in Invasive Ductal Carcinoma of the Breast: Relationship between β-Catenin, Disheveled and Cyclin D1 Expression. Oncology 73:1-2, pages 112-117.
Crossref
Crossref